1887

Abstract

The public health threat of orthopoxviruses from bioterrorist attacks has prompted researchers to develop suitable animal models for increasing our understanding of viral pathogenesis and evaluation of medical countermeasures (MCMs) in compliance with the FDA Animal Efficacy Rule. We present an accessible intrabronchial cowpox virus (CPXV) model that can be evaluated under biosafety level-2 laboratory conditions. In this dose-ranging study, utilizing cynomolgus macaques, signs of typical orthopoxvirus disease were observed with the lymphoid organs, liver, skin (generally mild) and respiratory tract as target tissues. Clinical and histopathological evaluation suggests that intrabronchial CPXV recapitulated many of the features of monkeypox and variola virus, the causative agent of smallpox, infections in cynomolgus macaque models. These similarities suggest that CPXV infection in non-human primates should be pursued further as an alternative model of smallpox. Further development of the CPXV primate model, unimpeded by select agent and biocontainment restrictions, should facilitate the development of MCMs for smallpox.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.036905-0
2012-01-01
2021-07-31
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/1/159.html?itemId=/content/journal/jgv/10.1099/vir.0.036905-0&mimeType=html&fmt=ahah

References

  1. Bras G. 1952; The morbid anatomy of smallpox. Doc Med Geogr Trop 4:303–351[PubMed]
    [Google Scholar]
  2. Bray M., Martinez M., Smee D. F., Kefauver D., Thompson E., Huggins J. W. 2000; Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J Infect Dis 181:10–19 [View Article][PubMed]
    [Google Scholar]
  3. Chapman J. L., Nichols D. K., Martinez M. J., Raymond J. W. 2010; Animal models of orthopoxvirus infection. Vet Pathol 47:852–870 [View Article][PubMed]
    [Google Scholar]
  4. Chen N., Li G., Liszewski M. K., Atkinson J. P., Jahrling P. B., Feng Z., Schriewer J., Buck C., Wang C., Lefkowitz E. 2005; Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 340:46–63 [View Article][PubMed]
    [Google Scholar]
  5. Councilman W. T., Magrath G. B., Brinckerhoff W. R. 1904; The pathological anatomy and histology of variola. J Med Res 11:12–135[PubMed]
    [Google Scholar]
  6. Earl P. L., Americo J. L., Moss B. 2003; Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein. J Virol 77:10684–10688 [View Article][PubMed]
    [Google Scholar]
  7. Earl P. L., Americo J. L., Wyatt L. S., Espenshade O., Bassler J., Gong K., Lin S., Peters E., Rhodes L. Jr other authors 2008; Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proc Natl Acad Sci U S A 105:10889–10894 [View Article][PubMed]
    [Google Scholar]
  8. Edghill-Smith Y., Bray M., Whitehouse C. A., Miller D., Mucker E., Manischewitz J., King L. R., Robert-Guroff M., Hryniewicz A. other authors 2005; Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J Infect Dis 191:372–381 [View Article][PubMed]
    [Google Scholar]
  9. FDA 2009; Guidance for Industry: Animal Models – essential elements to address efficacy under the animal rule. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078923.pdf
  10. Goff A. J., Chapman J., Foster C., Wlazlowski C., Shamblin J., Lin K., Kreiselmeier N., Mucker E., Paragas J. other authors 2011; A novel respiratory model of infection with monkeypox virus in cynomolgus macaques. J Virol 85:4898–4909 [View Article][PubMed]
    [Google Scholar]
  11. Hooper J. W., Thompson E., Wilhelmsen C., Zimmerman M., Ichou M. A., Steffen S. E., Schmaljohn C. S., Schmaljohn A. L., Jahrling P. B. 2004; Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol 78:4433–4443 [View Article][PubMed]
    [Google Scholar]
  12. Huggins J., Goff A., Hensley L., Mucker E., Shamblin J., Wlazlowski C., Johnson W., Chapman J., Larsen T. other authors 2009; Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother 53:2620–2625 [View Article][PubMed]
    [Google Scholar]
  13. Jahrling P. B., Hensley L. E., Martinez M. J., Leduc J. W., Rubins K. H., Relman D. A., Huggins J. W. 2004; Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci U S A 101:15196–15200 [View Article][PubMed]
    [Google Scholar]
  14. Johnson R. F., Dyall J., Ragland D. R., Huzella L., Byrum R., Jett C., St Claire M., Smith A. L., Paragas J. other authors 2011a; Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route. J Virol 85:2112–2125 [View Article][PubMed]
    [Google Scholar]
  15. Johnson R. F., Yellayi S., Cann J. A., Johnson A., Smith A. L., Paragas J., Jahrling P. B., Blaney J. E. 2011b; Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox. Virology 418:102–112 [View Article][PubMed]
    [Google Scholar]
  16. Kramski M., Mätz-Rensing K., Stahl-Hennig C., Kaup F. J., Nitsche A., Pauli G., Ellerbrok H. 2010; A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection. PLoS ONE 5:e10412 [View Article][PubMed]
    [Google Scholar]
  17. Lane J. M., Poland G. A. 2011; Why not destroy the remaining smallpox virus stocks?. Vaccine 29:2823–2824 [View Article][PubMed]
    [Google Scholar]
  18. Langohr I. M., Stevenson G. W., Thacker H. L., Regnery R. L. 2004; Extensive lesions of monkeypox in a prairie dog (Cynomys sp). Vet Pathol 41:702–707 [View Article][PubMed]
    [Google Scholar]
  19. Lefkowitz E. J., Upton C., Changayil S. S., Buck C., Traktman P., Buller R. M. 2005; Poxvirus Bioinformatics Resource Center: a comprehensive Poxviridae informational and analytical resource. Nucleic Acids Res 33:Database issueD311–D316 [View Article][PubMed]
    [Google Scholar]
  20. Lillie R. D. 1930; Smallpox and vaccinia: the pathologic histology. Arch Pathol (Chic) 10:241–291
    [Google Scholar]
  21. Martin D. B. 2002; The cause of death in smallpox: an examination of the pathology record. Mil Med 167:546–551[PubMed]
    [Google Scholar]
  22. Martina B. E., van Doornum G., Dorrestein G. M., Niesters H. G., Stittelaar K. J., Wolters M. A., van Bolhuis H. G., Osterhaus A. D. 2006; Cowpox virus transmission from rats to monkeys, the Netherlands. Emerg Infect Dis 12:1005–1007[PubMed] [CrossRef]
    [Google Scholar]
  23. Martinez M. J., Bray M. P., Huggins J. W. 2000; A mouse model of aerosol-transmitted orthopoxviral disease: morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system. Arch Pathol Lab Med 124:362–377[PubMed]
    [Google Scholar]
  24. Mätz-Rensing K., Ellerbrok H., Ehlers B., Pauli G., Floto A., Alex M., Czerny C. P., Kaup F. J. 2006; Fatal poxvirus outbreak in a colony of New World monkeys. Vet Pathol 43:212–218 [View Article][PubMed]
    [Google Scholar]
  25. McFadden G. 2010; Killing a killer: what next for smallpox?. PLoS Pathog 6:e1000727 [View Article][PubMed]
    [Google Scholar]
  26. Müller G., Meyer A., Gras F., Emmerich P., Kolakowski T., Esposito J. J. 1988; Monkeypox virus in liver and spleen of child in Gabon. Lancet 1:769–770 [View Article][PubMed]
    [Google Scholar]
  27. Parker S., Nuara A., Buller R. M., Schultz D. A. 2007; Human monkeypox: an emerging zoonotic disease. Future Microbiol 2:17–34 [View Article][PubMed]
    [Google Scholar]
  28. Reynolds M. G., Yorita K. L., Kuehnert M. J., Davidson W. B., Huhn G. D., Holman R. C., Damon I. K. 2006; Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis 194:773–780 [View Article][PubMed]
    [Google Scholar]
  29. Rimoin A. W., Mulembakani P. M., Johnston S. C., Lloyd Smith J. O., Kisalu N. K., Kinkela T. L., Blumberg S., Thomassen H. A., Pike B. L. other authors 2010; Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A 107:16262–16267 [View Article][PubMed]
    [Google Scholar]
  30. Seet B. T., Johnston J. B., Brunetti C. R., Barrett J. W., Everett H., Cameron C., Sypula J., Nazarian S. H., Lucas A., McFadden G. 2003; Poxviruses and immune evasion. Annu Rev Immunol 21:377–423 [View Article][PubMed]
    [Google Scholar]
  31. Stittelaar K. J., Kuiken T., de Swart R. L., van Amerongen G., Vos H. W., Niesters H. G., van Schalkwijk P., van der Kwast T., Wyatt L. S. other authors 2001; Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 19:3700–3709 [View Article][PubMed]
    [Google Scholar]
  32. Tucker J. B. 2011; Breaking the deadlock over destruction of the smallpox virus stocks. Biosecur Bioterror 9:55–67 [View Article][PubMed]
    [Google Scholar]
  33. Vorou R. M., Papavassiliou V. G., Pierroutsakos I. N. 2008; Cowpox virus infection: an emerging health threat. Curr Opin Infect Dis 21:153–156 [View Article][PubMed]
    [Google Scholar]
  34. Xing K., Deng R., Wang J., Feng J., Huang M., Wang X. 2006; Genome-based phylogeny of poxvirus. Intervirology 49:207–214 [View Article][PubMed]
    [Google Scholar]
  35. Zaucha G. M., Jahrling P. B., Geisbert T. W., Swearengen J. R., Hensley L. 2001; The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest 81:1581–1600[PubMed] [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.036905-0
Loading
/content/journal/jgv/10.1099/vir.0.036905-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error